Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.
Times cited: 166
EZH2 mutations are frequent and represent an early event in follicular lymphoma.
Times cited: 122
BRAF mutations in hairy-cell leukemia.
New England Journal of Medicine.
Times cited: 639